
Ambalal Sarabhai Enterprises Ltd is Rated Sell
2026-05-21 10:10:58Ambalal Sarabhai Enterprises Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read full news articleWhen is the next results date for Ambalal Sarabhai Enterprises Ltd?
2026-05-15 23:17:46The next results date for Ambalal Sarabhai Enterprises Ltd is scheduled for 21 May 2026....
Read full news article
Ambalal Sarabhai Enterprises Ltd is Rated Sell
2026-05-10 10:10:37Ambalal Sarabhai Enterprises Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance.
Read full news article
Ambalal Sarabhai Enterprises Ltd is Rated Sell
2026-04-29 10:10:53Ambalal Sarabhai Enterprises Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 29 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Ambalal Sarabhai Enterprises Ltd: Valuation Shifts Signal Changing Price Attractiveness
2026-04-28 08:01:40Ambalal Sarabhai Enterprises Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change reflects evolving market perceptions amid mixed financial metrics and a challenging sector backdrop, prompting investors to reassess the stock’s price attractiveness relative to its peers and historical benchmarks.
Read full news article
Ambalal Sarabhai Enterprises Ltd: Valuation Shifts Signal Renewed Price Attractiveness
2026-04-22 08:01:28Ambalal Sarabhai Enterprises Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a very attractive rating, despite a recent downgrade in its overall Mojo Grade to Sell. This change reflects a significant improvement in price-to-earnings and price-to-book value metrics, positioning the micro-cap pharmaceutical player favourably against its peers amid a backdrop of mixed stock performance and sector challenges.
Read full news article
Ambalal Sarabhai Enterprises Ltd is Rated Sell
2026-04-18 10:10:38Ambalal Sarabhai Enterprises Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Ambalal Sarabhai Enterprises Ltd is Rated Sell
2026-04-07 10:10:31Ambalal Sarabhai Enterprises Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 April 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Ambalal Sarabhai Enterprises Ltd is Rated Sell
2026-03-27 10:10:41Ambalal Sarabhai Enterprises Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 March 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 27 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news articleBoard Meeting Intimation for Approval Of Audited Financial Results As On 31.03.2026
14-May-2026 | Source : BSEAmbalal Sarabhai Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 inter alia to consider and approve Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended 31.03.2026 along with Audit Report thereon AGM Related matters and other general matters. You are requested to take the same on your records.
Intimation Regarding Change In Branch Address Of Registrar & Share Transfer Agent (MCS Share Transfer Agent Limited)
24-Apr-2026 | Source : BSEIntimation regarding change in Branch Address of RTA
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
21-Apr-2026 | Source : BSEFormat of the Annual Disclosure to be made by an entity identified as a Large Corporate.
| Sr. No. | Particulars | Details |
| 1 | Name of Company | Ambalal Sarabhai Enterprises Ltd |
| 2 | CIN NO. | L52100GJ1978PLC003159 |
| 3 | Report filed for FY | 2025-2026 |
| Details of the Current block (all figures in Rs crore): | ||
| 4 | 2 - year block period (Specify financial years)* | 2024-25 and 2025-26 |
| 5 | Incremental borrowing done in FY (T)(a) | 0.00 |
| 6 | Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) | 0.00 |
| 7 | Actual borrowing done through debt securities in FY (T)(c) | 0.00 |
| 8 | Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) | 0 |
| 8 | Quantum of (d) which has been met from (c)(e)* | 0 |
| 9 | Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* | 0 |
| Details of penalty to be paid if any in respect to previous block (all figures in Rs crore): | |
| 2 - year Block period (Specify financial years) | 2024-25 and 2025-26 |
| Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}# | 0.00 |
| Name of the Company Secretary :- | Disha Mahesh Punjani |
| Designation :- | Company Secretary and Compliance Officer |
| Name of the Chief Financial Officer :- | Jinal Shah |
| Designation : - | CFO |
Date: 21/04/2026
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






